CSL Behring Medical Expert Portal is a European webpage designed for healthcare professionals (HCPs) who are interested in serious and life-threatening conditions. Register and login to access the information on this webpage and to receive updates when new content becomes available. If you are interested in the relevant content for a specific country, please refer to the CSL Behring affiliate in your country to obtain relevant information. The medical and scientific information provided on this website is for informational purposes only and should not replace professional advice from a healthcare provider in your area. It is important that you always adhere to the regulations and guidelines relevant to your country.

Disclaimer: Due to compliance regulations, not all content of this webpage is intended for UK healthcare practitioners. If you would like to access UK specific materials on this site, please reach out to your local CSL Behring medical representative (medinfo@cslbehring.com) for assistance.

Disclaimer

CSL EXPERT HIVE

Science updates

14 Jan 2025

Attending EAHAD 2025? Mark your calendars!

Pathology:

Haemophilia B

The European Association for Haemophilia and Allied Disorders (EAHAD) congress aims to exchange knowledge on inherited or acquired bleeding disorders to improve clinical care. The 18th annual EAHAD Congress will be held from Tuesday 4th to Friday 7th February 2025 in Milan, Italy, with virtual access for registered delegates. Register to attend the EAHAD 2025 congress here.

The most recent findings and current issues in the world of bleeding disorders will be presented by leading experts in their fields. Come and join us at EAHAD 2025 to discuss the latest news, exchange ideas, broaden your knowledge, and experience Milan's beauty and gastronomy. You can read the welcome letter from the EAHAD 2025 Congress President, Flora Peyvandi, here.

CSL Behring will be organising and supporting another symposium at EAHAD 2025, discussing different aspects of implementation of gene therapy for haemophilia B in medical centres outside of the clinical trial setting, including the collaboration between hub and spoke and the role of the multidisciplinary team. This interactive symposium will include presentations by French experts who will discuss their real-world experiences in prescribing gene therapy for haemophilia B.

Join us for this exciting satellite symposium “First EU real-world gene therapy experiences in haemophilia B: Insights on getting your clinic ready” in-person or online on Wednesday 5th February; 11:30–12:45 CET.

We look forward to seeing you there!

EUR-HGX-0250